Clinical Trial Update: Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for IBI363 in combination with chemotherapy for MHC-II-negative locally advanced gastric cancer; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• IBI363

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: IBI363 + Chemotherapy | Phase 2 | Status: RECRUITING